You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Development and validation of therapy for mucopolysaccharidosis III
SBC: Phoenix Nest Inc. Topic: 103Project Summary Sanfilippo disease (mucopolysaccharidosis type III; MPS III) is a devastating neurodegenerative lysosomal storage disorder of childhood whose pathologic features are neurologic: slowing of development, severe behavioral problems, progressive cognitive decline, dementia, and decline in motor skills leading to immobility, unresponsiveness, and death. We have focused on MPS IIID cause ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Interstitial Intensity Modulated Photodynamic Therapy Phase II
SBC: SIMPHOTEK, INC. Topic: 102Photodynamic therapy (PDT) is a cancer treatment that utilizes visible or near-infrared light to activate a light- sensitive drug (photosensitizer, PS) that, in turn, creates reactive singlet oxygen species from ground triplet state oxygen that is present in the tumor. The resulting reactive products induce tissue death. Ideally the reactive species will be produced within only the target volume, ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Validation of a salivary miRNA diagnostic test for autism spectrum disorder
SBC: Quadrant Biosciences Inc. Topic: 103Autism spectrum disorder (ASD) is a continuum of neurodevelopmental characteristics that includes deficits in communication and social interaction, as well as restrictive, repetitive interests and behaviors. ASD is an increasing public health concern, with about 1 in 45 American children diagnosed with ASD in 2014, a 10-fold increase in prevalence over the past 40 years. The effect of ASD on both ...
STTR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Lab-To-Marketplace: Commercialization of a stretchable microelectrode array
SBC: BMSEED LLC Topic: 101Project Summary/Abstract The proposed work is directed at the commercialization of BMSEEDandapos;s Micro-Electrode Array Stretching Stimulating und Recording Equipment (MEASSuRE) technology. MEASSuRE bridges the gap between in vitro and in vivo research by simulating the biomechanical and electrical environment of cells in the body in a controlled environment outside of the body. The applications ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
pRBC Contaminant Removal with Hemocompatible Porous Polymer Beads
SBC: CYTOSORBENTS MEDICAL INC Topic: NHLBIPacked red blood cellpRBCtransfusions save livesHoweverhundreds of thousands of non hemolytic transfusion reactions occur each year worldwideranging from mild fever and pruritisto serious lifethreatening reactions such as severe hyperkalemiaanaphylaxisand transfusion related acute lung injuryTRALIMild moderate reactions drive patient discomfortdocumentationand testing costs while serious reactions ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Improved cleaning technology for reducing risk of transmitting infection in endoscopy.
SBC: ADVANCED BIODEVICES LLC Topic: R7. Project Summary/Abstract: Outbreaks of infection caused by contaminated endoscopes are a serious public health problem that has even resulted in patient deaths. Currently, because of the narrowness of the channels and complexity of the endoscope, there simply is no reliable way of achieving this. The existing cleaning protocols also are highly dependent on operator technique. Accordingly, this ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
pRBC Contaminant Removal with Hemocompatible Porous Polymer Beads
SBC: CYTOSORBENTS MEDICAL INC Topic: NHLBIPacked red blood cell (pRBC) transfusions save lives. However, hundreds of thousands of non-hemolytic transfusion reactions occur each year worldwide, ranging from mild fever and pruritis, to serious life- threatening reactions such as severe hyperkalemia, anaphylaxis, and transfusion-related acute lung injury (TRALI). Mild-moderate reactions drive patient discomfort, documentation, and testing co ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Painless Defibrillation
SBC: Coridea, LLC Topic: NHLBIProject SummaryThe purpose of the proposed work is first-in-man testing of novel painless defibrillation (PaDe) therapy. Sudden cardiac arrest (SCA) remains the number one killer in western civilization. The underlying mechanism of SCA is usually ventricular fibrillation (VF), and survival depends on prompt defibrillation. Existing defibrillators rely on the delivery of a brief high voltage shock ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Just-In-Time Essential Worker COVID-19 Mobile Awareness Campaign
SBC: CELL PODIUM LLC Topic: 142Summary/Abstract. Just-In-Time Essential Worker COVID-19 Mobile Awareness Campaign The objective of this effort is to improve essential worker safety through a just-in-time COVID-19 awareness training campaign. The campaign will push brief (under three minute) modules of interactive multimedia, tailored to the specific job of the worker, to the mobile devices of over 5,000 essential workers, track ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Development of Anti-ceramide scFv as Mitigator of the Radiation GI Syndrome
SBC: Ceramedix Holding, LLC Topic: NIAIDProject Summary/Abstract Inhibition of ceramide protects mice from death from the Radiation GI Syndrome (RGS). Administration of anti- ceramide single-chain Fv (scFv) 24 h post radiation exposure increases survival in intestinal stem cells and dramatically improves overall survival in mice. These data indicate that anti-ceramide scFv represents the first effective mitigator of lethal RGS. To advan ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health